J&J beats Vi­a­tris in patent fight over its an­tipsy­chot­ic drug, staving off com­pe­ti­tion

John­son & John­son scored an ap­peals court win in its bid to block gener­ic com­pe­ti­tion for its long-act­ing schiz­o­phre­nia drug.

The US Court of Ap­peals …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.